Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 173

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 173
---
,079,857 |
| Total                                                   |     | $                          | 23,843,798 |     | $       | - |     | $       | - |     | $     | 23,843,798 |

|                                                         |     | Fair Value Measurements at 
 June 30, 2023              |            |     |         |   |     |         |   |     |       |            |
|:--------------------------------------------------------|:----|:---------------------------|-----------:|:----|:--------|:--|:----|:--------|:--|:----|:------|-----------:|
|                                                         |     | Level 1                    |            |     | Level 2 |   |     | Level 3 |   |     | Total |            |
| Cash                                                    |     | $                          |  6,304,543 |     | $       | - |     | $       | - |     | $     |  6,304,543 |
| U.S. Treasury Bills due in 3 months or less at purchase |     |                            | 13,156,340 |     |         | - |     |         | - |     |       | 13,156,340 |
| U.S. Treasury Bills due in 3 - 6 months at purchase     |     |                            | 14,477,726 |     |         | - |     |         | - |     |       | 14,477,726 |
| Total                                                   |     | $                          | 33,938,609 |     | $       | - |     | $       | - |     | $     | 33,938,609 |

| 9. | Equity Transactions |

Issuance of common stock for cash

On August 31, 2022, the Company entered into a Controlled
Equity Offering Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co. and B. Riley Securities, Inc. (collectively,
the “Agents”), pursuant to which the Company may issue and sell from time-to-time shares of the Company’s common stock
through the Agents, subject to the terms and conditions of the Sales Agreement. On April 6, 2023, the Company and B. Riley Securities,
Inc. mutually agreed to terminate B. Riley Securities, Inc.’s role as a sales agent under the Sales Agreement. During the year ended
June 30, 2024, the Company sold 333